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D-chiro-inositol (DCI) and pinitol (1D-3-O-methyl-chiro-inositol) are distinctive inositols reported to possess insulin-mimetic properties. DCI-
containing compounds are abundant in common laboratory animal feed. By GC–MS of 6 M-HCl hydrolysates, Purina Laboratory Rodent Diet
5001 (diet 5001) contained 0·23 % total DCI by weight with most found in the lucerne and soya meal components. In contrast, only traces of
L-chiro-inositol were observed. The DCI moiety was present in a water-soluble non-ionic form of which most was shown to be pinitol. To measure
the absorption of dietary inositols, rats were fed diet 5001 in a balance study or given purified pinitol or [2H6]DCI. More than 98 % of the total DCI
fed to rats as diet 5001, purified pinitol or [2H6]DCI was absorbed from the gastrointestinal tract. Rats chronically on diet 5001 consumed
921mmol total DCI/kg body weight per d but excreted less than 5·3 % in the stools and urine, suggesting that the bulk was metabolised. The
levels of pinitol or DCI in plasma, stools or urine remained relatively stable in mice fed Purina PicoLabw Rodent Diet 20 5053 over a 5-week
period, whereas these values declined to very low levels in mice fed a pinitol/DCI-deficient chemically defined diet. To test whether DCI was
synthesised or converted from myo-inositol, mice were treated with heavy water or [2H6]myo-inositol. DCI was neither synthesised endogenously
from 2H-labelled water nor converted from [2H6]myo-inositol. DCI and pinitol in rodents appear to be derived solely from the diet.
Pinitol: Insulin: Mass spectrometry: Defined diets
The mechanism of insulin action is still incompletely under-
stood and the subject of active investigation. After insulin
binds to its cell surface receptor, many metabolic pathways
are activated. Interest in these secondary signalling systems
has resulted in the isolation of certain inositol phosphoglycan
molecules which mimic some actions of insulin, especially
those related to glucose oxidation and lipid metabolism(1 – 5).
Interestingly, the inositol present in some of these putative
insulin mediator preparations was predominantly or solely
D-chiro-inositol (DCI) (Fig. 1(a)), an epimer of myo-inositol
(MI) (Fig. 1(c)), which is the predominant mammalian inosi-
tol(6,7). DCI differs from MI only in the orientation of a
single hydroxyl group (labelled 6 in both DCI and MI). It is
this hydroxyl group by which MI is attached to phosphatidic
acid in phosphatidylinositol. The prefix ‘chiro’ refers to
the fact that this inositol has optically active D and L enantio-
mers. chiro-Inositol also has been identified in preparations
derived from the phosphatidylinositol anchors of membrane
proteins(8 – 10). Both the chemical structure and the
occurrence of DCI in insulin signalling molecules suggest
that it may have a physiological role in mammals. Pinitol
(1D-3-O-methyl-chiro-inositol) is structurally related to DCI,
having a methoxyl group at position 3 (Fig. 1(b)). Pinitol
was originally described in 1855 as a component of the
sugar pine tree(11). It is also a prominent component of
animal forage legumes(12) and is found in beans including
soyabeans(13,14).
Diabetic patients (both type 1 and type 2) have increased
urinary excretion of DCI, the magnitude of which correlates
with plasma glucose and glycated Hb levels(15). Pima Indians
with type 2 diabetes have low levels of muscle chiro-inosi-
tol(16). A similar abnormality in chiro-inositol excretion is
found in diabetic db/db mice and streptozotocin diabetic
rats(17). Although not all clinical trials have been positive(18),
at least some insulin-resistant patients appear to have
responded to treatment with DCI or pinitol with improved
insulin sensitivity(19,20).
Studies of animal and human treatment with pinitol or DCI
have been limited by lack of experimental control of dietary
intake and incomplete knowledge of DCI metabolism. MI, a
component of mixed diets(21), has been shown to be actively
absorbed in the small intestine of hamsters(22) and also is
synthesised from glucose(23 – 25). However, there is no infor-
mation about DCI absorption, and previous work on the poss-
ible bioconversion of DCI from MI has not given consistent
results. Inositol epimerase from bovine brain converted MI
to neo- and scyllo-inositol but not to chiro-inositol(26). In
cockroach fat body extracts, however, epimerisation of MI
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to chiro-inositol was observed(27). Injection of 3H-labelled MI
into rats showed conversion of MI to chiro-inositol as judged
by counts co-migrating with chiro-inositol(28).
In the present study we analysed dietary inositol contents of
commercial animal diets and studied the absorption of pinitol




Diisopropylidene pinitol and L-chiro-inositol were gifts of
Professor Laurens Anderson of the University of Wisconsin,
Madison. Pinitol containing less than 1 % DCI was
prepared from its isopropylidene derivative by hydrolysis in
0·1 M-HCl for 1 h at 1108C, followed by lyophilisation and
recrystallisation from 90 % ethanol(29). DCI was purchased
from Calbiochem. DL-1,2,3,4,5,6-[2H6]chiro-inositol
(30) was
the gift of Dr Ken Sasaki (Connaught Center for Biotechnol-
ogy Research, Toronto, ON, Canada). 1,2,3,4,5,6-[2H6]MI
was purchased from MSD Isotopes (Montreal, QC, Canada).
[2H3]pinitol labelled in the methyl radical was a gift of Dr
Andrew Falshaw (Industrial Research Ltd, Lower Hutt, New
Zealand). Ethanol-extracted casein (C3400) was purchased
from Sigma (St Louis, MO, USA).
Diets
Purina Laboratory Rodent Diet 5001 (diet 5001) and Purina
PicoLab Rodent Diet 20 5053 (diet 5053) were purchased
from LabDiet (Richmond, IN, USA). Basal Diet 5755 (diet
5755; a chemically defined diet) was purchased from TestDiet
(Richmond, IN, USA). Components of diet 5001 were kindly
supplied by Dr Daniel Hopkins. The pinitol/DCI-deficient diet
(Table 1) was based on diet 5755. The ingredients for both
diets were dextrin, casein, sucrose, mineral mix, vitamin
mix, cellulose, choline chloride, DL-methionine and fat.
Maize oil (5 %) and lard (5 %) were used in diet 5755 whereas
only soyabean oil (5 %) was used in our pinitol/DCI-deficient
diet. Components of diet 5755 were analysed for total DCI
and levels were generally very low. The original powdered
cellulose contained 0·014 nmol total DCI/mg and was replaced
by Avicelw cellulose (FMC Biopolymer, Philadelphia, PA,
USA), which contained non-detectable total DCI.
Gas chromatography–mass spectrometry
For inositol analysis in plasma and urine, 2H-labelled internal
standards for DCI, MI and pinitol were added and they were
then processed by protein precipitation and anion exchange
adsorption and dried as described previously(15). Urine
samples were further purified by solid-phase extraction.
They were taken up in 0·5 ml water, applied to a 1·0 ml Supel-
cleane LC-18 SPE column (Supelco, Bellefonte, PA, USA)
previously equilibrated with 2 ml methanol, eluted with 2 ml
water and lyophilised.
Both free and total inositols in feed are reported. To isolate
free inositols, dried mouse stool homogenate or 50 mg samples
of finely ground mouse chow received all three 2H-labelled
internal standards and were extracted with 0·5 ml water at
room temperature for 12 h. For total inositols, samples of
ground mouse chow or dried stool homogenate received
0·5 ml 6 M-HCl with 2H-labelled internal standards for DCI
and MI and were heated at 1108C for 24 h in tightly sealed
tubes. Total DCI contents measured by acid hydrolysis include
free and complex DCI such as inositol glycans or phosphates
and free and complex pinitol, since acid hydrolysis converts
pinitol to DCI and hydrolyses complex inositols to free
inositols. The acid hydrolysate was separated from charred
residue, dried under N2 at 858C and taken up in 0·5 ml
water. Samples were treated with anion exchange resins,
passed over 6 ml LC-18 solid phase extraction columns
(Supelco), and dried.
Lyophilised samples were derivatised for GC–MS by incu-
bation overnight with 10 % pentafluoropropionyl imidazole in
acetonitrile at 658C and then separated on a 25 m £ 0·25 mm
internal diameter Chirasil-Val fused silica capillary column
with 0·16mm film thickness (Alltech Associates, Deerfield,
Fig. 1. Structures of inositols: D-chiro-inositol (DCI) (a); pinitol (b); myo-inosi-
tol (c). DCI is numbered as recommended by the International Union of Pure
and Applied Chemistry(34). Pinitol and myo-inositol are numbered according
to the convention for DCI.





Soyabean oil Sam’s Club‡ 50·0
Cellulose FMC Biopolymer§ 33·2
Choline chloride TestDiet* 2·0
DL-Methione TestDiet* 2·0
Mineral mixk TestDiet* 50·0
Vitamin mix{ TestDiet* 50·0
ppm, Parts per million.
* Richmond, IN, USA.
† St Louis, MO, USA.
‡ Head Office: Bentonville, AR, USA.
§ Philadelphia, PA, USA.
kFinal concentration of mineral mix components in the diet,
as provided by the manufacturer: Ca, 0·60 %; P, 0·60 %; K,
0·40 %; Mg, 0·07 %; Na, 0·21 %; Cl, 0·24 %; F, 5·0 ppm;
Fe, 63·0 ppm; Zn, 21·0 ppm; Mn, 65·0 ppm; Cu, 15·0 ppm;
Co, 3·2 ppm; I, 0·57 ppm; Cr, 3·0 ppm; Mo, 0·82 ppm; Se,
0·23 ppm.
{Final concentration of vitamin mix in the diet, as provided by
the manufacturer: vitamin A, 22·1 IU/g (12·1mg/g); vitamin D3,
2·2 IU/g (0·055mg/g); vitamin E, 50·1 IU/kg (50·1 mg/kg);
vitamin K, as menadione, 10·4 ppm; thiamin hydrochloride,
20·6 ppm; riboflavin, 20·0 ppm; niacin, 90·0 ppm; pantothenic
acid, 55·0 ppm; folic acid, 4·0 ppm; pyridoxine, 16·5 ppm;
biotin, 0·4 ppm; vitamin B12, 20·0mg/kg; choline chloride,
1400 ppm; ascorbic acid, 0·0 ppm.

















IL, USA). The oven temperature was kept at 808C for
0·5 min, then raised at a rate of 608C/min to 1008C and held
for 4 min, and again raised at a rate of 208C/min to a final
temperature of 1858C and held for 3·5 min. The effluent was
analysed in an Agilent Technologies 5973 quadrupole
mass spectrometer by negative-ion chemical ionisation MS
using methane as the reagent gas (Hewlett Packard, Palo
Alto, CA, USA). Selected ion monitoring was performed
at m/z 573 and 576 (for natural and 2H-labelled pinitols,
respectively) and at m/z 726 and 731 (for natural and
2H-labelled chiro-inositols and MI).
The enrichment of 2H-labelled water in urine was
determined following alkaline exchange with acetone
according to the published protocol, except that hexane
rather than chloroform was used in the exchange
procedure(31). Exchanged acetone was separated isothermally
at 608C for 5 min on a 30 m £ 0·25 mm internal diameter
DB17-MS capillary column with 0·25mm film thickness
(J&W Scientific, Folsom, CA, USA). Selected ion monitoring
was performed at m/z 58 and 59 using electron impact
ionisation mode (70 eV). The incorporation of 2H from
2H-labelled water into MI was calculated by mass isotope
distribution analysis considering both 2H and natural 13C
enrichment.
Metabolic balance studies in rats fed Purina Rodent Diet 5001
or Basal Diet 5755
For metabolic balance studies, male Sprague–Dawley rats
weighing 400–500 g were fed diet 5001 for at least
1 month, then housed individually in metabolism cages and
fed powdered diets consisting of either diet 5001 or diet
5755 for 1 week. Dietary consumption was measured and
urine and faeces were collected for 24 h. The total amount
of DCI after HCl hydrolysis was measured by negative-ion
chemical ionisation GC–MS, and DCI balance was
computed as the difference between intake and output.
Institutional and national guidelines for the care and use of
animals were followed. All procedures involving animals
were approved by the Washington University Animal Studies
Committee.
Effect of stool bacteria on faecal total D-chiro-inositol levels
Equal amounts of stools from three rats fed diet 5001 were
pooled and dispersed in 0·15 M-NaCl to a concentration of
0·2 g/ml and MI and glucose were added to final concen-
trations of 30mM and 5·5 mM, respectively. Samples were
incubated for 24 h at either 48C (control for the measurements
at 378C) or 378C in anaerobic jars, after which internal
standards were added and the samples were hydrolysed and
processed by negative-ion chemical ionisation GC–MS for
total DCI content.
Absorption studies in rats fed Basal Diet 5755
Three rats weighing 427 (SEM 27) g were housed individually
in metabolism cages and fed diet 5755 for 3 d. Pinitol,
51·5mmol (10 mg), was then given orally; urine and stools
were collected for the following 2 d and analysed for total
DCI. Then 25 nmol [2H6]DCI was given orally followed by
an additional 2 d of urine and stool collection.
Inositol clearance over time in mice fed Purina PicoLabw
Rodent Diet 20 5053 or the pinitol/D-chiro-inositol-deficient
diet
Male C57BL/6J mice were fed diet 5053 for 1 week before
randomly being assigned to diet 5053 (n 8) or the pinitol/
DCI-deficient diet (n 8) for up to 5 weeks. Food intake was
recorded twice per week and body weight once per week.
Plasma, stools and urine were obtained before the experimen-
tal assignment (week 0), and at 1, 2 and 5 weeks after the diet
assignment. For each time point, urine and stools were
collected over a 24 h period in individual metabolism cages.
Pinitol, DCI and MI levels in plasma, stools or urine were
determined by GC–MS.
Measurement of inositol biosynthesis in mice fed the pinitol/
D-chiro-inositol-deficient diet
To measure endogenous inositol (DCI and MI) synthesis, male
C57BL/6J mice (n 3) were maintained on the pinitol/DCI-
deficient diet for 10 weeks. Then, mice were provided with
drinking water containing 20 % heavy water (2H-labelled
water, catalogue number 151882; Sigma-Aldrich) for 1 week
to label the ring hydrogens of inositols, followed by 24 h
urine collection in individual metabolism cages.
At 5 weeks later, [2H6]MI (1 mg in water) was administered
by intraperitoneal injection to each mouse (n 3, maintained on
the pinitol/DCI-deficient diet for 15 weeks before intraperito-
neal injection) to determine whether MI is converted into DCI
in vivo. Urine was collected for 24 h each before and after
injection. Urine samples were processed and GC–MS was
performed as described above.
Statistical analyses
Group data are reported as mean values with their standard
errors. Two-way repeated-measures ANOVA was used to
analyse diet, time and interactions between diet and time
with SAS Proc GLM (version 9.2; SAS Institute, Cary, NC,
USA). Multiple comparisons were performed using the
Tukey adjustment.
Results
Total acid-released D-chiro-inositol content of Purina rodent
chows
Total DCI measured by GC–MS after hydrolysis with
6 M-HCl at 1108C for 24 h was a prominent component of
laboratory animal chows (Table 2). Chows 5001 and 5053
each contained more than 4 nmol total DCI/mg. Diet 5001
contained 12·9 (SEM 1·2) nmol total DCI/mg or 0·23 % by
weight. DCI was present in diet 5001 in an amount approxi-
mately two-thirds that of MI, which was 20·2 (SEM 0·7)
nmol/mg or 0·36 % by weight following hydrolysis. Another
rodent chow, chow 5053, currently used in our animal facility,
contained comparable levels of total DCI at 10·94 (SEM 0·45)
nmol/mg (Table 2). Diet 5755 had only trace levels of

















total DCI and these levels were reduced even further in the
pinitol/DCI-deficient diet.
Analyses of chow components showed that maize, wheat,
meat, fish and dairy products contributed relatively little
DCI (Table 3). However, total DCI was very high in the
leguminous components of lucerne and soyabean meal in
which it constituted 1·3 and 1·0 % of weight, respectively, or
more than fifty times as much as in other chow components.
L-chiro-Inositol, in contrast, was very low in all ingredients.
The molecular form of DCI in diet 5001 was further
investigated. Finely ground chow was suspended at room
temperature in 1 M-HCl, then extracted and partitioned by
the method of Bligh & Dyer(32) to yield aqueous and organic
fractions. Less than 1 % of the total DCI was found in the
organic fraction; in contrast, 83 % was recovered in the
aqueous fraction with the remainder in the insoluble residue.
Thus, substantial amounts of DCI did not appear to be present
in phospholipids and DCI was present predominantly in the
water-soluble form. Only 6 % of the total DCI was measurable
without prior strong acid hydrolysis. The species containing
DCI did not appear to be ionic (such as a phytate) because
there was no change in the measured concentration when
the sample was treated with an AG 501-X8(D) mixed bed
ion exchange resin.
Metabolic balance studies in rats fed Purina Rodent Diet 5001
or Basal Diet 5755
Rats chronically fed diet 5001 consumed 921mmol total
DCI/kg body weight per d or 0·17 g total DCI/kg body
weight per d (Table 4). Only 0·7 % of total DCI intake was
found in the stool output, suggesting that gastrointestinal
absorption was essentially complete. Urinary output was
only 4·6 % of that consumed. The total excretion from the
urine and stools represents 5·3 % of the total DCI intake,
suggesting that the majority of the dietary inositols was
metabolised. Thus, total DCI balance was strongly positive
at 872·5 (SEM 79·0) mmol/kg body weight per d.
Effect of stool bacteria on faecal total D-chiro-inositol levels
Since bacterial degradation or production of DCI in the
gastrointestinal tract could have influenced these experiments,
rat stool samples were fortified with MI and glucose
(possible metabolic precursors of DCI) and then incubated
at 378C anaerobically for 24 h. A large amount of gas
was produced indicating active bacterial metabolism, but
little effect on measured total DCI levels was seen. There
was a 9·5 % decrease in total DCI after 378C incubation
Table 2. Nutrient composition of the diets*
Diet 5001† Diet 5053† Diet 5755‡ Pinitol/DCI-deficient diet
PFV (kJ/g)§ 13·98 14·24 17·12 15·95
By energy (%)
Protein 28·0 23·6 18·6 23·7
Fat 12·2 11·9 22·0 11·9
Carbohydrates 59·8 64·5 59·3 64·4
By weight (%)
Protein 23·4 20·0 19·0 22·5
Fat 4·5 4·5 10·0 5·0
SFA 1·50 0·84 2·72 0·74
MFA 1·58 1·04 3·31 1·06
PUFA 1·42 2·61 3·97 3·20
Carbohydrates 49·9 54·8 60·6 61·3
Fibre 5·3 4·7 4·3 4·6
Inositols (nmol/mg)
Free pinitol
Mean NA 7·09 0·0014 0·0008
SEM NA 0·02 0·0003 0·0001
Free DCI
Mean NA 0·16 NDk NDk
SEM NA 0·02 ND ND
Total DCI
Mean 12·9 10·94 0·0018 0·0012
SEM 1·2 0·45 0·0001 0·0003
Free MI
Mean NA 1·96 0·75 0·62
SEM NA 0·09 0·03 0·01
Total MI
Mean 20·2 41·1 1·07 0·68
SEM 0·07 8·6 0·05 0·06
Diet 5001, Purina Laboratory Rodent Diet 5001; diet 5053, Purina PicoLabw Rodent Diet 20 5053; diet 5755,
TestDietw 5755 Basal Diet; DCI, D-chiro-inositol; PFV, physiological fuel energy; NA, not analysed; ND, not
detectable; MI, myo-inositol.
* The mouse chows and the pinitol/DCI-deficient diet (n 3, about 50 mg each) were weighed. Free (for pinitol,
DCI and MI) and total (for DCI and MI) inositols were determined as described in Materials and methods.
The rest of nutrient composition was from the manufacturers.
† Purchased from LabDiet (Richmond, IN, USA).
‡ Purchased from TestDiet (Richmond, IN, USA).
§ Sum of decimal fractions of protein, fat and carbohydrates multiplied by 16·8, 37·7 and 16·8 kJ/g, respectively.
kThe limit of detection for DCI is 0·0003 nmol/mg.

















(10·54 (SEM 0·27) nmol/ml at 48C v. 9·85 (SEM 0·19) nmol/ml
at 378C; P¼0·052), suggesting that a small amount of degra-
dation might have occurred. Stool L-chiro-inositol was
unchanged by incubation (1·11 (SEM 0·36) nmol/ml at 48C v.
1·32 (SEM 0·11) nmol/ml at 378C). Bacterial degradation or
metabolism, therefore, could not account for the quantitative
reduction of total DCI in stools compared with the diet.
Absorption studies in rats fed Basal Diet 5755
The gastrointestinal absorption of purified pinitol was studied
next (Table 5). At 3 d before the experiment, rats were
switched from diet 5001 to diet 5755 low in total DCI in
order to reduce excretion of total DCI to approximately
0·5mmol/kg body weight per d. Then 10 mg pinitol (contain-
ing 51·5mmol total DCI) was given orally and the faecal
and urinary excretion of total DCI was measured. Most of
the material eliminated was excreted on day 1 when faecal
loss was 0·9 % of intake and urinary loss was 21 %. These
data suggest that pinitol is absorbed from the gastrointestinal
tract and most is retained or metabolised. That somewhat
more total DCI appeared in urine (21 %) compared with diet
5001 feeding (4·6 %; Table 4) may be due to the large
single pinitol bolus administered. The day after pinitol
feeding, total excretion in urine and faeces was similar to
baseline.
Similar results were obtained when labelled free DCI tracer
was given orally (Table 5). Absorption, estimated by recovery
of [2H6]DCI in the stools for 2 d, was 98 %. The urinary output
was only 14 % of that administered, consistent with incom-
plete urinary excretion.
Inositol clearance over time in mice fed Purina PicoLabw
Rodent Diet 20 5053 or the pinitol/D-chiro-inositol-deficient
diet
After a more defined diet was developed, we studied the
clearance of inositols over a longer period of time. There
were time and diet effects and interactions between time and
diet effects on the food intake (Fig. 2(a)) and body weight
(Fig. 2(b)). Food intakes (Fig. 2(a)) and body weights
(Fig. 2(b)) were statistically different at 1, 2, 3, 4 and 5
weeks between the two diets.
Both pinitol (Fig. 3(a), (c) and (e)) and DCI (Fig. 3(b),
(d) and (f)) in plasma, stools or urine remained relatively
stable over the 5-week period for the mice fed diet 5053. In
contrast, both pinitol and DCI in these various compartments
declined rapidly to a very low level over the 5-week period in
mice fed the pinitol/DCI-deficient diet. Repeated-measures
ANOVA showed that there was a diet effect on pinitol and
DCI concentrations in plasma, stools or urine (Fig. 3). This
indicates that the diet plays an important role in pinitol or
DCI levels. A time effect was observed for all measurements
except for stool pinitol, stool DCI or urine DCI. A time and
diet interaction was seen for all parameters except for stool
DCI. The differences at weeks 1, 2 and 5 between diet 5053
and the pinitol/DCI-deficient diet in all inositol measurements
were statistically significant (P,0·001).
Endogenous D-chiro-inositol/myo-inositol biosynthesis
from 2H-labelled water in mice fed the pinitol/
D-chiro-inositol-deficient diet
To determine whether the carbon ring hydrogen atoms of DCI
were synthesised endogenously from water, male C57BL/6J
mice (n 3) were fed the pinitol/DCI-deficient diet for 10
weeks and received drinking water containing 20 % (w/w)
2H-labelled water for 1 week followed by a 24 h urine
collection while housed in metabolism cages. The resulting
concentration of 2H-labelled water in urine was 8·70
(SEM 0·52) % as determined by equilibration with acetone
followed by GC–MS. Neither natural nor 2H-labelled DCI
could be detected in the urine (,0·0067 nmol/ml). In contrast,
2H-labelled MI was present in the urine and it was cal-
culated that 34·4 (SEM 2·8) % of urinary MI was derived by
biosynthesis from body water.
Table 4. Metabolic balance of total D-chiro-inositol (DCI) in
rats fed Purina Rodent Diet 5001*
(Mean values with their standard errors)
Mean SEM
Rat weight (g) 471 35
Chow consumed (g/d) 33·2 1·6
Stools produced (g/d) 9·4 0·7
DCI intake (mmol/kg body weight per d) 921·0 84·0




DCI balance (mmol/kg body weight per d) 872·5 79·0
* Rats (n 3) were fed Purina Rodent Diet 5001 for at least 1 month and
housed in individual metabolism cages for 1 week. Dietary consump-
tion was measured and urine and faeces were collected for 24 h. The
total amount of DCI after HCl hydrolysis was measured by negative-
ion chemical ionisation GC–MS, and DCI balance was computed as
the difference between intake and output.
Table 3. Total chiro-inositol content of components of Purina Rodent
Diet 5001







Wheat germ 1·011 0·008
Ground oats 0·758 0·028
Fish meal 0·676 0·012
Ground beet pulp 0·248 0·003
Meat meal 0·058 0·004
Yeast 0·049 0·014
Middlings 0·049 0·015
Ground maize 0·044 0·003
Bleachable fat 0·018 0·001
Molasses 0·010 0·004
Whey 0·009 0·001
* Values for lucerne and soya for six replicates.
† L-chiro-Inositol could not be measured accurately in the presence of the large
amount of D-chiro-inositol but it constituted less than 2 % of D-chiro-inositol.

















Conversion of myo-inositol to D-chiro-inositol in mice fed the
pinitol/D-chiro-inositol-deficient diet
Male C57BL/6J mice (n 3) were maintained on the chemically
defined pinitol/DCI-deficient diet for 15 weeks and then given
1·0 mg [2H6]MI by intraperitoneal injection. Following a 24 h
isotope equilibration period, urine was collected in individual
metabolism cages. [2H6]MI constituted 38·7 (SEM 11·5) % of
urinary MI after labelling, which indicated a large enrichment
of the endogenous MI pool. Ionic masses corresponding to
natural DCI (m/z 726) through to fully labelled DCI (m/z
731) were scanned, but no natural DCI or DCI with any
amount of 2H labelling was detected (,0·0067 nmol/ml).
Discussion
Total DCI levels were unexpectedly high in common labora-
tory animal chows and constituted 0·23 % of the weight of
diet 5001 (Table 2). The amounts consumed by animals
were very large; for example, rats chronically ingested
166 mg total DCI/kg body weight per d while on diet 5001
(Table 4). Thus, a potential source of DCI is abundant in
laboratory animal diets, principally in the legumes lucerne
and soyabeans, which are ingredients of many commercial
laboratory animal chows. However, meat and other animal
products contained little total DCI. L-chiro-Inositol was
present only in small amounts relative to DCI (Table 3). In
lucerne and soyabeans, at least 98 % of the total chiro-inositol
was the D-enantiomer. In diet 5053, only 1·5 % of the DCI was
present in the free form, whereas 65 % was found in free
pinitol. Another 33·5 % of DCI is in complex forms such as
glycosides liberated by acid hydrolysis. In contrast to
common rodent chows, diet 5755 and our pinitol/DCI-
deficient diet had only trace amounts of total DCI (Table 2).
In the equilibrium state on diet 5001, there was a markedly
positive total DCI balance of 872·5mmol/kg body weight per d
(Table 4). DCI must have been metabolised, since only about
5·3 % was recovered in the stools (0·7 %) and urine (4·6 %).
The complete absorption (99·3 %) of total DCI suggests that
both free and complex forms of pinitol or DCI were absorbed
from the diet. Their complete absorption from the gastrointes-
tinal tract was further confirmed by using purified pinitol and
Table 5. Gastrointestinal absorption of pinitol and [2H6]D-chiro-inositol (DCI) in rats fed Basal
Diet 5755*
(Mean values with their standard errors)
Dietary intake Faecal output Urinary output Total output
Mean SEM Mean SEM Mean SEM Mean SEM
Pinitol feeding
Total DCI (mmol/kg body weight per d)
Pre-pinitol 0·09 0·02 0·07 0·02 0·48 0·31 0·54 0·31
Pinitol, day 1 122 7·4 1·11 0·53 26·0 1·7 27·11 0·56
Pinitol, day 2 0·07 0·01 0·10 0·01 0·38 0·11 0·47 0·12
[2H6]DCI feeding
Free [2H6]DCI (nmol/kg body weight per d)
Day 1 59·1 3·6 0·15 0·1 4·0 0·4 4·2 0·2
Day 2 ND 1·0 1·0 4·3 0·1 5·3 1·1
ND, not detectable.
* Three rats weighing 427 ^ 27 g were housed individually in metabolism cages and fed Purina Basal Diet 5755
for 3 d. Pinitol, 51·5mmol (10 mg), was given orally with urine and stools collected for the following 2 d, which were
analysed for total DCI. Then 25 nmol [2H6]DCI was given orally, followed by an additional 2 d of urine and stool
collection. No [2H6]DCI was detectable before isotope administration.
Fig. 2. Food intakes (a) and body weights (b) of mice fed Purina PicoLabw Rodent Diet 20 5053 (diet 5053) (X) or a pinitol/D-chiro-inositol (DCI)-deficient diet (W).
Male C57BL/6J mice (eight mice per diet) were fed diet 5053 or the pinitol/DCI-deficient diet for 5 weeks. Food intake was measured twice per week and the
average represents weekly food intake (g/d). Body weight was determined at the beginning and once per week. Values are means, with standard errors
represented by vertical bars. ** Mean value was significantly different from that of the mice fed diet 5053 (P,0·001). Effects of diet (P¼0·0002), time (P,0·0001)
and interactions between time and diet (P,0·0001) were statistically significant.

















[2H6]DCI, since less than 2 % of the orally administered
material was recovered in the stools (Table 5). More urinary
output was observed on day 1 with feeding the natural pinitol
than with the oral administration of [2H6]DCI, suggesting
that their metabolic kinetics differed.
It has been reported previously that soil bacteria transform
labelled MI into chiro-inositol(30). Although the extent of
conversion was small (4 % over 12 d), the possibility of
bacterial synthesis or degradation of chiro-inositol in the
large bowel was considered in our experiments under anaero-
bic incubation mimicking colonic fermentation. However, no
net synthesis of DCI was found and only a small amount of
DCI was degraded. Faecal bacteria do not appear, therefore,
to be an important source of DCI in these animals.
Since pinitol is of plant origin(33), it is expected to come
exclusively from the diet. Thus pinitol in the plasma, stools
or urine fell rapidly to a very low level over the 5-week
period after switching from diet 5053 to the pinitol/DCI-
deficient diet (Fig. 3(a), (c) and (e)). By contrast, pinitol
levels in the same three compartments remained relatively
stable when mice were fed diet 5053 (Fig. 3(a), (c) and (e)).
Similarly, DCI fell rapidly to an extremely low level in the
plasma, stools or urine of mice fed the pinitol/DCI-deficient
diet, in contrast to relatively stable levels of these inositols
in mice fed diet 5053 (Fig. 3(b), (d) and (f)). In fact,
plasma, stools or urinary levels of pinitol or DCI were not
detectable in mice fed the pinitol/DCI-deficient diet for 10
weeks. These results strongly suggest that DCI in body
fluids derives from the diet and not from endogenous biosyn-
thesis. Indeed, 2H-labelled water was not incorporated into
2H-labelled DCI, indicating no endogenous synthesis of DCI
from body water hydrogen. In contrast, 34·4 % of urinary
MI was synthesised from 2H-labelled water, consistent with
endogenous synthesis of MI in the literature(23).
Bioconversion of MI to DCI appears not to occur in mice.
2H-labelled DCI was not detected in the urine of mice 24 h
after intraperitoneal injection of [2H6]MI. The injected
[2H6]MI constituted 38·7 (SEM 11·5) % of urinary MI, indicat-
ing good enrichment of the putative precursor.
Inconsistent results have been obtained in the past regarding
conversion of MI to DCI. Inositol epimerase from bovine
brain led to conversion of MI to neo- and scyllo-inositol but
not chiro-inositol(26). In cockroach fat body extracts, however,
epimerisation of MI to chiro-inositol was observed(27). More
recently, Pak et al. injected 37 MBq of [3H]MI intraperitone-
ally into rats over 3 d and found that it was converted to
radioactive counts that co-migrated with chiro-inositol(28).
The percentage conversion was very large, 8 % in blood,
Fig. 3. Plasma, stool and urine inositols over time in mice fed Purina PicoLabw Rodent Diet 20 5053 (diet 5053) (X) or a pinitol/D-chiro-inositol (DCI)-deficient diet
(W): plasma pinitol (a); plasma DCI (b); stool free pinitol (c); stool free DCI (d); urine pinitol (e); urine DCI (f). Male C57BL/6J mice (eight mice per diet) were fed
diet 5053 or the pinitol/DCI-deficient diet for 5 weeks. Blood, urine and stools were obtained at 0, 1, 2 and 5 weeks. Pinitol and DCI were analysed as described in
Materials and methods. Values are means, with standard errors represented by vertical bars. ** Mean value was significantly different from that of the mice fed
diet 5053 (P,0·001).

















9 % in liver and 36 % in urine. However, DCI natural abun-
dance of total inositols (sum of chiro-inositol and MI) is
only 0·4 % in plasma and 2·3 % of urinary inositols in
humans(15). Furthermore, the ratio of basal (when all mice
were on diet 5053) urinary DCI to urinary MI was barely
10·0 % in the present study. This raises the possibility
that some of the counts co-migrating with chiro-inositol on
paper chromatograms may not have been chiro-inositol.
Furthermore, the method used did not distinguish D- from
L-chiro-inositol(28).
Our time-course study in mice comparing diet 5053 and the
pinitol/DCI-deficient diet showed little change in body weight
in either group over 5 weeks. However, mice in the pinitol/
DCI-deficient diet weighed less (Fig. 2(b)) and had less food
intake (Fig. 2(a)) when compared with those on diet 5053.
We speculate that this could be due to differences in MI,
DCI or other nutrients, or to reduced palatability of the pinitol/
DCI-deficient diet. This experiment was performed to test
whether or not DCI was synthesised endogenously rather
than testing the function of DCI in the diet, which requires
further research.
In conclusion, pinitol and DCI are present in large amounts
in rodent chow diets and they are avidly absorbed from chow
5001. DCI was not synthesised in vivo or converted from
[2H6]MI, suggesting that, like pinitol, it derives solely from
the diet. The present study suggests that dietary control of ino-
sitols should be considered for future research in diabetes and
insulin resistance. The chemically defined diet 5755 and the
pinitol/DCI-deficient diet described here establish a deficient
baseline for future control studies, and are suitable for the
determination of the effects of DCI and pinitol on glucose
and lipid metabolism.
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